Smit EF - Search Results

1

Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.

Li BT, Smit EF, Goto Y, Nakagawa K, Udagawa H, Mazières J, Nagasaka M, Bazhenova L, Saltos AN, Felip E, Pacheco JM, Pérol M, Paz-Ares L, Saxena K, Shiga R, Cheng Y, Acharyya S, Vitazka P, Shahidi J, Planchard D, Jänne PA; DESTINY-Lung01 Trial Investigators. Li BT, et al. Among authors: smit ef. N Engl J Med. 2022 Jan 20;386(3):241-251. doi: 10.1056/NEJMoa2112431. Epub 2021 Sep 18. N Engl J Med. 2022. PMID: 34534430 Free PMC article. Clinical Trial.

2

Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.

Smit EF, Piers DA, Postmus PE. Smit EF, et al. Eur J Cancer. 1992;28A(12):1965-7. doi: 10.1016/0959-8049(92)90238-w. Eur J Cancer. 1992. PMID: 1329882 Clinical Trial.

3

Small-cell lung cancer: is there a standard therapy?

Postmus PE, Smit EF. Postmus PE, et al. Among authors: smit ef. Oncology (Williston Park). 1998 Jan;12(1 Suppl 2):25-30. Oncology (Williston Park). 1998. PMID: 9516608 Free article. Review.

4

Effects of gemcitabine on renal function in patients with non-small cell lung cancer.

Gietema JA, Groen HJ, Meijer S, Smit EF. Gietema JA, et al. Among authors: smit ef. Eur J Cancer. 1998 Jan;34(1):199-202. doi: 10.1016/s0959-8049(97)00354-7. Eur J Cancer. 1998. PMID: 9624259

5

Evaluation of new drugs in small cell lung cancer: the activity of gemcitabine.

Postmus PE, Schramel FM, Smit EF. Postmus PE, et al. Among authors: smit ef. Semin Oncol. 1998 Aug;25(4 Suppl 9):79-82. Semin Oncol. 1998. PMID: 9728590 Review.

6

A dose and schedule finding study of gemcitabine and etoposide in patients with progressive non-small cell lung cancer after platinum containing chemotherapy.

Biesma B, Smit EF, Postmus PE. Biesma B, et al. Among authors: smit ef. Lung Cancer. 1999 May;24(2):115-21. doi: 10.1016/s0169-5002(99)00033-1. Lung Cancer. 1999. PMID: 10444062 Clinical Trial.

7

Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer.

Kroep JR, Giaccone G, Voorn DA, Smit EF, Beijnen JH, Rosing H, van Moorsel CJ, van Groeningen CJ, Postmus PE, Pinedo HM, Peters GJ. Kroep JR, et al. Among authors: smit ef. J Clin Oncol. 1999 Jul;17(7):2190-7. doi: 10.1200/JCO.1999.17.7.2190. J Clin Oncol. 1999. PMID: 10561275 Clinical Trial.

8

Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a review.

Huisman C, Smit EF, Giaccone G, Postmus PE. Huisman C, et al. Among authors: smit ef. J Clin Oncol. 2000 Nov 1;18(21):3722-30. doi: 10.1200/JCO.2000.18.21.3722. J Clin Oncol. 2000. PMID: 11054445 Review.

9

Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling.

Huisman C, Giaccone G, van Groeningen CJ, Sutedja G, Postmus PE, Smit EF. Huisman C, et al. Among authors: smit ef. Lung Cancer. 2001 Aug-Sep;33(2-3):267-75. doi: 10.1016/s0169-5002(01)00187-8. Lung Cancer. 2001. PMID: 11551422 Clinical Trial.

10

Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.

Hoekstra CJ, Hoekstra OS, Stroobants SG, Vansteenkiste J, Nuyts J, Smit EF, Boers M, Twisk JW, Lammertsma AA. Hoekstra CJ, et al. Among authors: smit ef. J Nucl Med. 2002 Oct;43(10):1304-9. J Nucl Med. 2002. PMID: 12368367 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

514 results

Search Page